This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ichnos Sciences Sa. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Olivia Hall and Her Patent in Antibody Innovation.
Introduction
Olivia Hall is an inventor associated with Neuchâtel, Switzerland, and Ichnos Sciences SA. Her recorded patent work concerns trispecific antibodies, an area of biotechnology research focused on designing antibodies that can engage multiple targets.
Latest Patents
Hall is associated with one patent, 1 patent: “CD3/BCMA/CD38 Trispecific Antibodies.” The invention concerns antibodies designed to target CD3, BCMA, and CD38.
Career Highlights
Hall’s listed patent reflects work connected to antibody-based research and development at Ichnos Sciences SA. The available information identifies her as an inventor but does not provide further details about her role or career history.
Collaborations
Hall’s listed coworkers include Maria Pihlgren Bosch and Rebecca Croasdale-Wood. Their names are associated with her professional context at Ichnos Sciences SA.
Conclusion
Olivia Hall’s recorded contribution is a patent on CD3/BCMA/CD38 trispecific antibodies, linking her inventor profile with antibody innovation at Ichnos Sciences SA.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile